GFI1 Is Repressed by p53 and Inhibits DNA Damage-Induced Apoptosis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Du, Pei ^a   Tang, Fangqiang ^a   Qiu, Yaling ^a   Dong, Fan ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LUCIFERASE; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GFI1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DOWN REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYMPHOMA; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE; DNA; DNA DAMAGE; DNA-BINDING PROTEINS; DOWN-REGULATION; HEMATOPOIESIS; HUMANS; MICE; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84883392652     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073542     Document Type: Article

References (47)

1. Kazanjian A, Gross EA, Grimes HL, (2006) The growth factor independence-1 transcription factor: new functions and new insights. Crit Rev Oncol Hematol 59: 85-97.
2. Moroy T, Khandanpour C, (2011) Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation. Semin Immunol 23: 368-378.
3. Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T, (2004) Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J 23: 4116-4125.
4. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, et al. (2004) Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Natue 431: 1002-1007.
5. Khandanpour C, Kosan C, Gaudreau MC, Duhrsen U, Hebert J, et al. (2011) Growth Factor Independence 1 (Gfi1) Protects Hematopoietic Stem Cells Against Apoptosis But Also Prevents the Development of a Myeloproliferative-Like Disease. Stem Cells 29: 376-385.
6. Kazanjian A, Wallis D, Au N, Nigam R, Venken KJ, et al. (2004) Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells. Cancer Res 64: 6874-6882.
7. Schmidt T, Zornig M, Beneke R, Moroy T, (1996) MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene. Nucleic Acids Res 24: 2528-2534.
8. Scheijen B, Jonkers J, Acton D, Berns A, (1997) Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J Virol 71: 9-16.
9. Schmidt T, Karsunky H, Gau E, Zevnik B, Elsasser HP, et al. (1998) Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene 17: 2661-2667.
10. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG, (2004) RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32: D523-527.
11. Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Akagi K, et al. (2006) High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res 64: 4419-4427.
12. Uren AG, Kool J, Matentzoglu K, de Ridder J, Mattison J, et al. (2008) Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133: 727-741.
13. Dabrowska MJ, Dybkaer K, Johnsen HE, Wang B, Wabl M, et al. (2009) Loss of MicroRNA targets in the 3′ untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1. J Virol 83: 8051-8061.
14. Yamasaki N, Miyazaki K, Nagamachi A, Koller R, Oda H, et al. (2010) Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia. Oncogene 29: 1963-1975.
15. Gilks CB, Bear SE, Grimes HL, Tsichlis PN, (1993) Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol 13: 1759-1768.
16. Grimes HL, Gilks CB, Chan TO, Porter S, Tsichlis PN, (1996) The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. Proc Natl Acad Sci U S A 93: 14569-14573.
17. Zhu J, Guo L, Min B, Watson CJ, Hu-Li J, et al. (2002) Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 16: 733-744.
18. Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T, (1996) Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene 12: 1789-1801.
19. Khandanpour C, Phelan JD, Vassen L, Schutte J, Chen R, et al. (2013) Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia. Cancer Cell 23: 200-214.
20. Horman SR, Velu CS, Chaubey A, Bourdeau T, Zhu J, et al. (2009) Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood 113: 5466-5475.
21. Soliera AR, Mariani SA, Audia A, Lidonnici MR, Addya S, et al. (2012) Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1. Leukemia 26: 1555-1563.
22. Zilfou JT, Lowe SW, (2009) Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 1: a001883.
23. Olivier M, Hollstein M, Hainaut P, (2010) TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2: a001008.
24. Laptenko O, Prives C, (2006) Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 13: 951-961.
25. Beckerman R, Prives C, (2010) Transcriptional regulation by p53. Cold Spring Harb Perspect Biol 2: a000935.
26. Rinn JL, Huarte M, (2011) To repress or not to repress: this is the guardian's question. Trends Cell Biol 21: 344-353.
27. Dong F, van Buitenen C, Pouwels K, Hoefsloot LH, Lowenberg B, et al. (1993) Distinct cytoplasmic regions of the human granulocyte colony- stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 13: 7774-7781.
28. McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA, (2010) Leukocytic promotion of prostate cellular proliferation. Prostate 70: 377-389.
29. Dahl R, Iyer SR, Owens KS, Cuylear DD, Simon MC, (2007) The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction. J Biol Chem 282: 6473-6483.
30. Aprikyan AA, Kutyavin T, Stein S, Aprikian P, Rodger E, et al. (2003) Cellular and molecular abnormalities in severe congenital neutropenia. Exp Hematol 31: 372-381.
31. La Rosee P, Johnson K, O'Dwyer ME, Druker BJ, (2002) In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia. Exp Hematol 30: 729-737.
32. Waldman T, Kinzler KW, Vogelstein B, (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187-5190.
33. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
34. Chipuk JE, Maurer U, Green DR, Schuler M, (2003) Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4: 371-381.
35. Barde I, Zanta-Boussif MA, Paisant S, Leboeuf M, Rameau P, et al. (2006) Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol Ther 13: 382-390.
36. Basu S, Liu Q, Qiu Y, Dong F, (2009) Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc Natl Acad Sci U S A 106: 1433-1438.
37. Liu Q, Basu S, Qiu Y, Tang F, Dong F, (2010) A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A. Oncogene 29: 2843-2852.
38. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI, (2006) The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443: 214-217.
39. Wang B, Xiao Z, Ko HL, Ren EC, (2010) The p53 response element and transcriptional repression. Cell Cycle 9: 870-879.
40. Menendez D, Inga A, Resnick MA, (2009) The expanding universe of p53 targets. Nat Rev Cancer 9: 724-737.
41. Nakazawa Y, Suzuki M, Manabe N, Yamada T, Kihara-Negishi F, et al. (2007) Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression. Oncogene 26: 3541-3550.
42. Pargmann D, Yücel R, Kosan C, Saba I, Klein-Hitpass L, et al. (2007) Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphocyte function. Eur J Immunol 37: 3551-3563.
43. Cheung KJ, Horsman DE, Gascoyne RD, (2009) The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target. Br J Haematol 146: 257-269.
44. Xu-Monette ZY, Medeiros LJ, Li Y, Orlowski RZ, Andreeff M, et al. (2012) Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. Blood 119: 3668-3683.
45. Ho JS, Ma W, Mao DY, Benchimol S, (2005) p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol 25: 7423-7431.
46. Zeng Y, Kotake Y, Pei XH, Smith MD, Xiong Y, (2011) p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb. Cancer Res 71: 2781-2792.
47. Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, et al. (2009) p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4: 37-48.